Victims of tainted drug face long wait for relief Complex process to pay victims of tainted steroids By Todd Wallack | GLOBE STAFF OCTOBER 02, 2013

Within weeks after Dee Morell received a tainted shot to treat arthritis in her left hip in September last year, she knew something was horribly wrong.

The 49-year-old X-ray technician started to feel worse, not better. Walking grew difficult, she needed constant painkillers, and for the past 10 months she has been too weak to work, making it a struggle to pay the mortgage.

But a year after federal investigators traced a nationwide fungal meningitis outbreak to contaminated steroids made by a Massachusetts pharmacy, Morell and hundreds of others who received the drugs are still waiting to find out how much compensation they will collect and when they will receive the money.

“Everything about this is frustrating,” said Morell, who was diagnosed with a hip infection. “It would be of great help if the money was released immediately. I wouldn’t have to worry about losing my home.”

continue to read Boston Globe here

Lawmakers in the House who sponsored the bill -- including Reps. Morgan Griffith (R-Va.) and Gene Green (D-Texas) -- admitted in statements that the legislation does little to address the issues of office stock and repacking of sterile products.

quoted from here

Iowa Board of Pharmacy List of Nonresident Pharmacies

view here

Pet Med Outsourcing: PE’s New Doggie Bag: Not only recently but also In 2009 Huntington Capital invested in Eaton Veterinary Pharmaceutical Inc. d/b/a as Roadrunner and estimated the veterinary compounding business to be a $125 million dollar business and growing--so how much money does veterinary compounding bring in these days; and if Eaton was filling 800 to 900 prescriptions a day and shipping them around the country to 9000 nationwide clinics in 2009 (which grew to 11000 in 2012) why isn't Congress dealing with Veterinary compounding in the current legislation?

• October 29, 2009, 5:14 PM

By Beina Xu

Attention, investors: there’s a new emerging market.

Veterinary compounding pharmacies. Put simply, they’re outsourced medication pharmacies that compound, or adjust the size and dosage, of drugs for your pets. And it’s caught the attention of one mezzanine firm.

San Diego-based Huntington Capital invested a mezzanine loan in Phoenix-based Eaton Veterinary Pharmaceutical Inc., or Roadrunner Pharmacy, which specializes in compounding back-ordered and discontinued pet medications. Partner Tim Bubnack said the commitment was on the low end of the firm’s typical sweet spot of $1.5 million to $5 million.

“It’s a business that’s grown fairly quickly in a market that’s really emerging right now,” he said. “People want better products for their pets, and they’re willing to pay for them.”

Eaton fills 800 to 900 prescriptions a day and ships them around the country. The company will use the growth capital to expand its sales team and develop of its own assortment of in-house drugs that will undergo tests through clinical trials, Bubnack said. Eaton, founded in 1999, sells to over 9,000 veterinary clinics nationwide.

The market for pet medication compounding is a bit tough to measure as many vets still handle the process themselves, instead of outsourcing, but Huntington estimates it to be approaching $125 million and growing. Bubnack says vets are finding it increasingly difficult and costly to carry large inventories of drugs. “They’re there to treat the animal, not build a business around prescriptions,” Bubnack said.

“They’re moving away from handling that in-house to the outsourcing model.”

The trend has also been propped up by the increasing complexity of pet medications, including modifications for specific breeds, Bubnack said. “The regular off the shelf drug might be right for the cat you have, but maybe not for the pit bull down the street.”

quoted from here

Another Note of Interest: A consumer researching Eaton Veterinary Pharmaceuticals would not only need to know it does business as Roadrunner ...the consumer would also need to know there are Minority interest owners such as Ampersand Capital Partners

An Edwards Wildman team in Boston represented Ampersand Capital Partners in the May 2012 acquisition of a minority interest in Eaton Veterinary Pharmaceuticals company. Ampersand Capital Partners is aprivate equity firm based in Wellesley, Massachusetts.

quoted from here

Note of Interest: In 1997 When Bayer sued Eaton Veterinary Laboratories in Federal Court for Trademark Infringement--Eaton was owned by Galleon One Inc. D/B/A Easton Veterinary Laboratories. This is a another reason for more transparency, something this blog has advocated since its beginning. Consumers of compounding medications would not know that when researching Roadrunner they would also need to look under multiple other names to find information.

U.S. District Court
Western District of Missouri (Kansas City)
CIVIL DOCKET FOR CASE #: 4:97-cv-00194-ODS

Bayer Corporation v. Galleon One Inc Assigned to: Judge Ortrie D Smith Demand: $0 Cause: 15:1125 Trademark Infringement (Lanham Act)

Date Filed: 02/20/1997 Date Terminated: 12/23/1998 Jury Demand: None Nature of Suit: 840 Trademark Jurisdiction: Federal Question

Plaintiff
Bayer Corporation	represented by	Jack D Rowe  Lathrop & Gage LLP - KCMO 2345 Grand Avenue Suite 2200 Kansas City, MO 64108-2618 (816)292-2000 Fax: (816)292-2001 Email: jrowe@lathropgage.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Ronald C. Provenzano  Kirkland & Ellis 200 East Randolph Drive 60th Floor Chicago, IL 60601 312-861-2000 LEAD ATTORNEY ATTORNEY TO BE NOTICED Jennifer Anderson Van Kirk  Kirkland & Ellis 200 East Randolph Drive 60th Floor Chicago, IL 60601 312-861-2000 ATTORNEY TO BE NOTICED Tefft W. Smith  Kirkland & Ellis 200 East Randolph Drive 60th Floor Chicago, IL 60601 312-861-2000 ATTORNEY TO BE NOTICED William A. Rudy  Lathrop & Gage LLP - KCMO 2345 Grand Avenue Suite 2200 Kansas City, MO 64108-2618 (816) 292-2000 Fax: (816) 292-2001 Email: wrudy@lathropgage.com ATTORNEY TO BE NOTICED
V.
Defendant
Galleon One Inc doing business as Eaton Veterinary Laboratories	represented by	Gerald M. Kraai  Lathrop & Gage LLP - OPKS 10851 Mastin Boulevard Building 82 Suite 1000 Overland Park, KS 66210-2007 (913) 451-5100 Fax: 913-451-0875 Email: gkraai@lathropgage.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Michael Elbein  Hovey Williams LLP 10801 Mastin Ste. 1000 Overland Park, KS 66210 (913) 647-9050 Fax: (913) 647-9050 Email: mme@hoveywilliams.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Michael W. Sillyman  Kutak Rock 3300 N. Central, 16th Fl. Phoenix, AZ 85012 (602) 285-1700 TERMINATED: 07/21/1997 LEAD ATTORNEY ATTORNEY TO BE NOTICED Peggy D. Richardson  Moniteau County Courthouse 200 E. Main California, MO 65018 (573) 796-4671 TERMINATED: 07/18/1997 ATTORNEY TO BE NOTICED

Date Filed	#	Docket Text
02/20/1997	1	COMPLAINT w/JS44 ( 1 Summons(es) issued) Receipt # 128432 $150.00 pd (Shannon Brogan) (Entered: 02/20/1997)
02/20/1997	2	Notice of Control Group Assignment (Early Assessment Program) (Shannon Brogan) (Entered: 02/20/1997)
03/04/1997	3	RETURN OF SERVICE executed upon defendant Galleon One Inc on 2/27/97 Costs $ 257.15 (Court Employee) (Entered: 03/05/1997)
03/06/1997	4	Motion/Order for pro hac vice on behalf of Bayer Corporation by Ronald C. Provenzano Receipt #: 128688 in the amount of $25.00 (Susan Larson) (Entered: 03/07/1997)
03/06/1997	5	Motion/Order for pro hac vice on behalf of Bayer Corporation by Jennifer A. Anderson Receipt #: 128688 in the amount of $25.00 (Susan Larson) (Entered: 03/07/1997)
03/06/1997	6	Motion/Order for pro hac vice on behalf of Bayer Corporation by Tefft W. Smith Receipt #: 128688 in the amount of $25.00 (Susan Larson) (Entered: 03/07/1997)
03/14/1997	7	Motion/Order for pro hac vice on behalf of Galleon One Inc by Michael W. Sillyman Receipt #: #128852 in the amount of $25.00 (Susan Larson) (Entered: 03/14/1997)
03/18/1997	8	MOTION by defendant Galleon One Inc to dismiss , or in the alternative to transfer case to the District of Arizona (Susan Larson) (Entered: 03/19/1997)
03/26/1997	9	MOTION by plaintiff Bayer Corporation to extend time to respond to dft's motion to dismiss and for leave to depose Robert L. Eaton Jr (Susan Larson) (Entered: 03/26/1997)
04/03/1997	10	Response by defendant Galleon One Inc to plt's motion to extend time to respond to dft's motion to dismiss [9-1], plt's motion leave to depose Robert L. Eaton Jr [9-2] (Susan Larson) (Entered: 04/03/1997)
04/08/1997	11	ORDER by Judge Ortrie D. Smith granting dft's motion to extend time to respond to dft's motion to dismiss [9-1], granting motion for leave to depose Robert L. Eaton Jr [9-2]; plf shall have 30 days from the date of this order to file a response to dft's motion to dismiss (cc: all counsel) (Georgia Kee) (Entered: 04/09/1997)
04/08/1997	12	ORDER by Judge Ortrie D. Smith ; proposed scheduling order due on or before 5/29/97 ;rule 26(f) meeting on or before 5/19/97 (cc: all counsel) (Georgia Kee) (Entered: 04/09/1997)
04/21/1997	13	Notice by plaintiff Bayer Corporation of filing compliance statement (Court Employee) (Entered: 04/22/1997)
05/06/1997	14	MOTION by defendant Galleon One Inc to vacate , or, alternatively to stay the Court's order setting deadline f/filing of joint proposed scheduling order & f/Rule 26(f) Conference (Georgia Kee) (Entered: 05/06/1997)
05/06/1997	15	1st AMENDED COMPLAINT Number of summon(s): 0 (Georgia Kee) (Entered: 05/07/1997)
05/20/1997	17	Suggestions by plaintiff Bayer Corporation in opposition to motion to vacate [14-1], motion to stay the Court's order setting deadline f/filing of joint proposed scheduling order & f/Rule 26(f) Conference [14-2] (Georgia Kee) (Entered: 05/20/1997)
05/22/1997	18	Reply suggestions by defendant Galleon One Inc to motion to dismiss [8-1], motion to transfer case to the District of Arizona [8-2] (Georgia Kee) (Entered: 05/22/1997)
05/27/1997	19	Reply suggestions in support of its by defendant Galleon One Inc to motion to vacate [14-1], motion to stay the Court's order setting deadline f/filing of joint proposed scheduling order & f/Rule 26(f) Conference [14-2] (Georgia Kee) (Entered: 05/27/1997)
06/03/1997	20	Suggestions by plaintiff Bayer Corporation in opposition to motion to dismiss [8-1] (Georgia Kee) (Entered: 06/04/1997)
06/03/1997	21	Report of Parties' Rule 26 Disclosure by plaintiff Bayer Corporation, defendant Galleon One Inc (Georgia Kee) (Entered: 06/04/1997)
06/16/1997	22	CERTIFICATE by defendant Galleon One Inc of service of Rule 26(A)(1)) Initial Disclosures (Georgia Kee) (Entered: 06/17/1997)
06/18/1997	23	Reply suggestions by defendant Galleon One Inc to motion to dismiss [8-1] (Georgia Kee) (Entered: 06/18/1997)
06/20/1997	24	ENTRY OF APPEARANCE on behalf of defendant Galleon One Inc by Michael Elbein, Gerald M. Kraai (Georgia Kee) (Entered: 06/20/1997)
06/30/1997	25	MOTION by defendant Galleon One Inc to withdraw attorney Peggy D. Richardson (Georgia Kee) (Entered: 06/30/1997)
07/07/1997	26	CERTIFICATE by plaintiff Bayer Corporation of service of 1st req to produce docs (Georgia Kee) (Entered: 07/08/1997)
07/07/1997	27	CERTIFICATE by plaintiff Bayer Corporation of service of 3rdpty subpoenas served on George Darnell, Dennis Darnell, Dr. Choi, Dr. Steve Kennedy, Dr. Paul Toogood, Dr. James K. Waldsmith, Dr. Banez, Dr. Ken Baker, Sprint Intl Comm Corp & US West Inc (Georgia Kee) (Entered: 07/08/1997)
07/16/1997	28	MOTION by defendant Galleon One Inc to withdraw attorney Michael W. Sillyman (Georgia Kee) (Entered: 07/17/1997)
07/16/1997	29	CERTIFICATE by plaintiff Bayer Corporation of service of subpoena in a civil case (Susan Larson) (Entered: 07/17/1997)
07/17/1997	30	CERTIFICATE by defendant Galleon One Inc of service of 1st request for production of documents (Susan Larson) (Entered: 07/18/1997)
07/18/1997	31	ORDER by Judge Ortrie D. Smith granting motion to withdraw attorney Peggy D. Richardson [25-1] attorney Peggy D. Richardson for Galleon One Inc (cc: all counsel) (Georgia Kee) (Entered: 07/21/1997)
07/21/1997	32	ORDER by Judge Ortrie D. Smith granting counsel f/dft's motion to withdraw attorney Michael W. Sillyman [28-1] attorney Michael W. Sillyman for Galleon One Inc (cc: all counsel) (Georgia Kee) (Entered: 07/21/1997)
07/30/1997	33	CERTIFICATE by defendant Galleon One Inc of service of Response to plf's req f/prod of docs (Georgia Kee) (Entered: 07/30/1997)
08/08/1997	34	ORDER by Judge Ortrie D. Smith denying dft's motion to dismiss [8-1] denying dft's motion to transfer case to the District of Arizona [8-2] (cc: all counsel) (Georgia Kee) (Entered: 08/08/1997)
08/08/1997	35	SCHEDULING & TRIAL ORDER: by Judge Ortrie D. Smith ; discovery ddl set 3/31/98;final pretrial conference set for 9:00 a.m. on 7/24/98 ;jury trial set 9:00 a.m. on 8/24/98 (cc: all counsel) (Georgia Kee) (Entered: 08/08/1997)
08/08/1997	36	RULES of trial by Judge Ortrie D. Smith (Georgia Kee) (Entered: 08/08/1997)
08/11/1997	37	Stipulation for entry of protective order of plaintiff Bayer Corporation, defendant Galleon One Inc (Georgia Kee) (Entered: 08/12/1997)
08/13/1997	38	PROTECTIVE ORDER by Judge Ortrie D. Smith : granting stipulation [37-1]; see order f/further details (cc: all counsel) (Georgia Kee) (Entered: 08/13/1997)
08/21/1997	39	ANSWER by defendant Galleon One Inc to 1st amd cmp (Georgia Kee) (Entered: 08/22/1997)
09/05/1997	40	CERTIFICATE by plaintiff Bayer Corporation of service of 1st req f/prod of docs (Georgia Kee) (Entered: 09/08/1997)
11/03/1997	41	CERTIFICATE by plaintiff Bayer Corporation of service of 3rd pty subpoenas & notices of depo (Georgia Kee) (Entered: 11/04/1997)
11/04/1997	42	CERTIFICATE by plaintiff Bayer Corporation of service of req to produce supplemental documents (Georgia Kee) (Entered: 11/05/1997)
11/12/1997	43	CERTIFICATE by plaintiff Bayer Corporation of service of Request to produce things (Georgia Kee) (Entered: 11/13/1997)
11/13/1997	44	CERTIFICATE by plaintiff Bayer Corporation of service of notice of deposition (Susan Larson) (Entered: 11/14/1997)
11/17/1997	45	CERTIFICATE by defendant Galleon One Inc of service of Response to Bayer's Supplemental Req f/prod of docs (Georgia Kee) (Entered: 11/18/1997)
12/08/1997	46	CERTIFICATE of transmission of deposition of Jae Choi, D.V.M. taken on 11/19/97 on behalf of plaintiff Bayer Corporation Costs: $249.55 (Court Employee) (Entered: 12/08/1997)
12/12/1997	47	CERTIFICATE by defendant of service of resp to pla's 3rd req f/prod ofdocus (Court Employee) (Entered: 12/12/1997)
12/17/1997	48	ORDER by Judge Ortrie D. Smith it is ordered that the Scheduling & Trial order dated 8/8/97 be struck & the court proceedings by stayed until 6/15/98; on or before 6/15/98, the parties shall file a joint status report informing the Court whether this case should be rescheduled for trial (cc: all counsel) (Georgia Kee) (Entered: 12/17/1997)
12/24/1997	49	CERTIFICATE of transmission of deposition of George W. Darnell taken on 11/21/97 on behalf of plaintiff Bayer Corporation Costs: $257.95 by pd plf (Georgia Kee) (Entered: 12/24/1997)
12/29/1997	50	CERTIFICATE of transmission of deposition of Sandra Tye taken on 12/9/97 on behalf of plaintiff Bayer Corporation Costs: $185.85 pd by plf (Georgia Kee) (Entered: 12/29/1997)
03/05/1998	51	NOTICE by defendant Galleon One Inc of change of address (Georgia Kee) (Entered: 03/06/1998)
06/12/1998	52	Joint Written status report by plaintiff Bayer Corporation, defendant Galleon One Inc (Georgia Kee) (Entered: 06/12/1998)
06/19/1998	53	SCHEDULING & TRIAL ORDER: by Judge Ortrie D. Smith ; discovery ddl set 12/31/98 ;pretrial conference 10:00 a.m. on 4/30/99 ;jury trial set 8:30 a.m. on 6/14/99 (cc: all counsel) (Georgia Kee) (Entered: 06/22/1998)
08/20/1998	54	CERTIFICATE by plaintiff Bayer Corporation of service of Supplement Responses to its 1st req to produce docs (Georgia Kee) (Entered: 08/20/1998)
08/24/1998	55	CERTIFICATE by plaintiff Bayer Corporation of service of 1st set of Interr to dft (Georgia Kee) (Entered: 08/25/1998)
09/14/1998	56	CERTIFICATE by plaintiff Bayer Corporation of service of Protective Order (Georgia Kee) (Entered: 09/15/1998)
09/22/1998	57	CERTIFICATE by defendant Galleon One Inc of service of req f/prod of supplemental docs (Georgia Kee) (Entered: 09/22/1998)
09/24/1998	58	MOTION by defendant Galleon One Inc to extend time to respond to plf's 1st set of Interr (Georgia Kee) (Entered: 09/24/1998)
09/29/1998	59	CERTIFICATE by plaintiff Bayer Corporation of service of 30(b)(6) deposition of dft (Georgia Kee) (Entered: 09/30/1998)
10/01/1998	60	CERTIFICATE by defendant Galleon One Inc of service of Responses to plf's 1st set of Interr (Georgia Kee) (Entered: 10/01/1998)
10/05/1998	61	ORDER by Judge Ortrie D. Smith granting dft's motion to extend time to respond to plf's 1st set of Interr [58-1] up to & including 9/30/98 (cc: all counsel) (Georgia Kee) (Entered: 10/06/1998)
10/20/1998	62	Request w/dft's consent by plaintiff Bayer Corporation for an extension of time to designate experts & file expert affidavits w/suggs in support (Georgia Kee) (Entered: 10/21/1998)
10/26/1998	63	CERTIFICATE by defendant Galleon One Inc of service of 1st set of Interr (Georgia Kee) (Entered: 10/26/1998)
10/26/1998	64	ORDER by Judge Ortrie D. Smith granting request that the time set for the exchange of expert witness designations & affidavits are modified [62-1] (cc: all counsel) (Georgia Kee) (Entered: 10/26/1998)
11/20/1998	65	(REQUEST) MOTION by plaintiff Bayer Corporation to extend time to respond to dft's 1st set of Interr (Georgia Kee) (Entered: 11/23/1998)
11/24/1998	66	CERTIFICATE by defendant Galleon One Inc of service of 2nd set of Interr & 1st req f/admission to plf (Georgia Kee) (Entered: 11/24/1998)
12/01/1998	67	ORDER by Judge Ortrie D. Smith granting plf's motion to extend time to respond to dft's 1st set of Interr [65-1] to & including 12/7/98 (cc: all counsel) (Georgia Kee) (Entered: 12/02/1998)
12/03/1998	68	MOTION by plaintiff Bayer Corporation to extend time to respond to dft's 1st set of interros (Court Employee) (Entered: 12/03/1998)
12/08/1998	69	ORDER by Judge Ortrie D. Smith granting plf's motion to extend time to respond to dft's 1st set of interros [68-1] up to & including 12/16/98 (cc: all counsel) (Georgia Kee) (Entered: 12/09/1998)
12/23/1998	70	ORDER by Judge Ortrie D. Smith this action is hereby dismissed w/prejudice to dismiss case (cc: all counsel) (Georgia Kee) (Entered: 12/24/1998)

---

PACER Service Center
Transaction Receipt
09/02/2013 19:00:27
PACER Login:	st6374	Client Code:
Description:	Docket Report	Search Criteria:	4:97-cv-00194-ODS
Billable Pages:	5	Cost:	0.50

Fourth Question of the Day October 1, 2013 Does having a degree in interior design, nursing and culinary arts and being the owner of a boutique qualify someone to own a veterinary compounding pharmacy or to make veterinary compounded medications? Should animal owners be more aware of who the makers and owners of veterinary compounding pharmacies are? Should there be requirements as has been suggested on the blog before that veterinary compounding pharmacies be a speciality in pharmacy schools and special licenses be required to make these types of compounded preparations?

Linda Obele

Phoenix Business Journal

Bold businesswoman builds ode to girliness

Sabrina Eaton always has enjoyed wearing different hats -- which makes sense, considering she owns a north Phoenix boutique that features more than 3,000 square feet of accessories and fashion items. But when she talks about wearing many hats, she could just as easily be discussing her varied business interests.

"I've always been very curious about a lot of things," said Eaton, owner of Sabrina's Boutique at Seventh Street and the Carefree Highway. "And I've always loved a challenge. If something interests me, I just go for it."

Her formal education includesdegrees in interior design, nursing and culinary arts. She's worked as an interior designer, a nurse and owner of a medical lab/pharmacy.

In 1995, Eaton and her husband, Robert, decided to capitalize on her medical training by founding Eaton Labs and Road�Runner Pharmacy, which customized medications for people and animals. She still runs both the lab and the pharmacy, and is working to secure a patent for a medication that treats dry eyes in pets.

Three years ago, realizing they had outgrown their quarters, the Eatons designed and built Tuscani Pointe, a 90,000-square-foot retail center that houses the lab, the pharmacy and Sabrina's Boutique, her ode to girliness.

For more: www.sabrinasboutiqueaz.com.

quoted from here

Third Question of the Day October 1, 2013 Is there Really this Much Money Being Made in the Veterinary Pharmaceutical and Compounding Industry? Eaton Veterinary Pharmaceutical, Inc. d/b/a Roadrunner Pharmacy Revenue is $27 million

Eaton Veterinary Pharmaceutical, Inc.

711 East Carefree Highway Suite 140 , Phoenix , AZ , 85085 , United States

www.roadrunnerpharmacy.com

Phone: +1 623 434 1180

Revenue: $27M

Industry: Pharmaceuticals - Diversified

Employees: 35

SIC: Drugs (2830)

NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)

Description:Eaton Veterinary Pharmaceutical, Inc., doing business as Roadrunner Pharmacy, operates veterinary compounding pharmacies. It specializes in compounding back-ordered and discontinued veterinary medications for veterinarians and their patients in the United States. The company was founded in 1999 and is based in Phoenix, Arizona.

2013-07-20 06:35:36

Contacts - VIEW DETAILS

GM/Managing Director(s)

Becky Sheehan, General Manager

Director(s)

Bruce Dell, Director of Business Development

Other

David Parker, Director

Roadrunner Pharmacy (Formerly Eaton VeterinaryPharmaceutical, Inc.) 

Second Question of the Day October 1, 2013 Does this type of illegal activity still occur in the veterinary or animal medication world? Does the EPA or State Agriculture Agencies Still Get Involved?

News Releases By Date

EATON VETERINARY LAB (also known as Roadrunner) ORDERED TO STOP SELLING ILLEGAL PET PRODUCTS

Release Date: 2/9/2000

Contact Information: Paula Bruin, U.S. EPA, (415) 744-1587

SAN FRANCISCO -- The U.S. Environmental Protection Agency today issued Stop Sale Orders against Eaton Veterinary Laboratories of Phoenix, Ariz., for selling unregistered flea products. The company sold and distributed unregistered versions of the popular flea-control products "Advantage for Dogs," "Advantage for Cats," "Frontline Top Spot Cat," and "Frontline Top Spot Dog."

Both Advantage and Frontline products are missing required labeling information about how to use the products safely. The unregistered Frontline pet products must include the warning that children are prohibited from applying the product. Also missing from the label is the restriction that the product must not be reapplied for 30 days. The unregistered Advantage pet products are missing language on the label about First Aid instructions and storage and disposal requirements.

The EPA will not register a pesticide until it has been tested to show that it will not pose an unreasonable risk when used according to the directions. The Agency also makes sure that pesticide labels provide consumers with the information they need to use the products safely. Pesticide products that have undergone this review process are recognizable by the EPA registration number printed on the label.

There has been a recent increase in the number of companies bringing unregistered pet products into the United States. Last year EPA assessed a fine against a San Diego pet store for selling unregistered Advantage for Dogs and Advantage for Cats. Also, a Stop Sale Order was issued to a distributor for importing unregistered Advantage products from Mexico with Spanish labeling.

The EPA's Action today was based on inspections conducted by Arizona Department of Agriculture and Virginia Department of Agriculture and Consumer Services.

Legislation defines when FDA can take action against compounders October 1, 2013 | By Eric Palmer

This week, Congress is expected to firm up FDA authority over compounding pharmacies like the one tied to last year's fatal outbreak of fungal meningitis. It will also give it stepped-up authority over those compounders that see enough market advantage that they volunteer to be regulated and pay a $15,000-a-year fee for the privilege.

"The question is, why would anybody ask for that? The answer is that 90% of hospitals outsource some of their compounding, and we hope that they will elect to buy from those facilities that operate under FDA oversight and those higher standards," explained Allan Coukell, a drug-policy expert at the Pew Charitable Trusts, which supports the legislation. "I think some will do it."

Read more: Legislation defines when FDA can take action against compounders - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/legislation-defines-when-fda-can-take-action-against-compounders/2013-10-01#ixzz2gVoyzD4d
Subscribe at FiercePharma Manufacturing